SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently a focal point for investors due to ongoing buyout discussions involving Stripe and Advent, fueling significant speculation about a potential deal premium. Community members are actively debating fair value, with many expressing skepticism toward initial offers and holding out for a substantially higher price before a deal is reached.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is trending as investors show renewed confidence in its commercial scaling, with community discussion focused on its robust manufacturing moat and anticipation of pivotal lung cancer trial updates. Market participants are actively debating the potential for a short squeeze as institutional ownership grows and excitement builds for upcoming clinical data readouts later this year.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is facing heightened volatility and intense community debate as the price struggles to maintain the psychological support level of $1. Investors remain sharply divided, with bulls highlighting heavy whale accumulation and potential regulatory clarity as catalysts, while bears point to ongoing token dilution and failed technical breakouts as reasons for further downside.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing significant volatility driven by investor concerns over customer concentration and AI-related financing risks, though the community remains divided between those capitalizing on the dip and others worried about the stock's software security vulnerabilities and recent price pressure. Many traders are actively debating whether this is a temporary pullback ahead of earnings or a sign of deeper structural issues, with active sentiment balanced between buying the discount and cautious technical monitoring.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently seeing intense community focus as traders anticipate significant volatility around upcoming earnings, with many pointing to a combination of strong pre-announced revenue growth and heavy short interest as a setup for a potential short squeeze. Investors are actively debating the company's long-term execution and expansion into AI infrastructure while navigating concerns over past financing activities and the lack of a firm earnings release date.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is gaining attention as investors weigh the company's recent earnings miss and operational status against optimism regarding its behind-the-meter power assets in Texas. The community is heavily focused on the potential for a transformative data center tenant agreement, with many speculating that the company's independent energy model positions it as a strategic partner for major AI infrastructure developers.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind the company's recent Samsung patent settlement and new legal actions against Micron, which many believe will trigger a massive short squeeze. The community is actively discussing the stock's long-term growth potential and momentum, with many longs refusing to sell and expressing high conviction that these legal developments are just the beginning of a larger institutional turnaround.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is seeing increased volatility as investors weigh the stock's sensitivity to jet fuel costs against a backdrop of ongoing Middle Eastern geopolitical tensions and shifting peace deal narratives. The community remains divided, with active debates centered on whether current price levels reflect long-term structural recovery or if persistent inflationary pressures and rising fuel expenses create a significant downside risk for the company.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is under investor scrutiny as it navigates a transition following the end of TDAPA reimbursement, with community sentiment divided between concerns over a projected revenue decline and optimism regarding potential growth from the DaVita commercial agreement. Shareholders are actively debating the leadership's ability to maintain momentum and provide clear guidance, while institutional accumulation and high short interest remain central talking points in the ongoing volatility.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heavy volatility as investors weigh the potential for a massive short squeeze against significant institutional interest, all while anticipation builds for the critical Phase 3 LUGANO trial readout. Community members are actively debating the company's competitive positioning in the wet AMD market and closely monitoring option activity and institutional holdings for signs of a breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Traders Are Piling into These Emerging Healthcare Names as New Catalysts Emerge

Biotechnology and healthcare innovation dominated investor conversations today as multiple companies delivered meaningful corporate, clinical, regulatory, and commercialization updates. From artificial intelligence-powered drug discovery platforms to neuro-oncology, regenerative medicine, wound care technologies, and autoimmune disease therapies, investors focused on companies that could potentially benefit from major industry trends while advancing important milestones of their own. $CUPR, $HYFT, $NTHI, $RGNT, $GELS, $SABS

What's Going On With Gelteq Stock Friday?

Micro-cap biotechnology stock Gelteq (GELS) faces erratic price swings, pulling back after a 200% spike. Stock down 33%.read more...

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China

Others

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

Gelteq to Present at Investor Summit Virtual on December 9, 2025

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform

Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound

Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.

Gelteq Ltd.

Gelteq Stock Soars On Deal With Healthy Extracts For Product Distribution In North America: Retail Chatter Explodes

Equity

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.58
Prev Close	$0.581
Open	$0.612
Dividend Yield	0.00%
50-Day Moving Average	$0.6604
Beta	1.35
Avg. Volume	111,525.83
PE Ratio	-1.30

52-Week High	$2.02
52-Week Low	$0.387
Market Capitalization	$6.22M
EPS (Annual)	-$0.4292
Price to Book	0.69
Revenue Per Employee	$5,959.83

Feed

News

Sentiment

Fundamentals

Info